To maintain the polarity of MPE-Mφ in vitro, CLS1 cancer cells-derived CM was used and showed concentration-dependently increasing the level of HLA-DR/CD163 expression, and expression plateaued at 75% CM (Fig. 2b) with no cytotoxicity (p = 0.1753, Fig. 2c). This evidence concerns the gene CD163 and cancer.